Q2 2022 Apellis Pharmaceuticals Inc Earnings Call Transcript
Ladies and gentlemen, thank you for standing by, and welcome to the Apellis Pharmaceuticals Second Quarter 2022 Earnings Call. (Operator Instructions)
I would now like to turn the call over to your host, Meredith Kaya. You may begin.
Good afternoon, and thank you for joining us to discuss Apellis' Second Quarter 2022 Financial Results. With me on the call are Co-Founder and Chief Executive Officer, Dr. Cedric Francois, Chief Commercial Officer, Adam Townsend; Chief Medical Officer, Dr. Federico Grossi; and Chief Financial Officer, Tim Sullivan.
Before we begin, I would like to point out on Slide 3 that we will be making forward-looking statements that are based on our current expectations and beliefs. These statements are subject to certain risks and uncertainties, and our actual results may differ materially. I encourage you to consult the risk factors discussed in our SEC filings for additional detail.
Now I'll turn the call over to Cedric.
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |